Clinical trial
Trenza Embolization Device for Intrasaccular Aneurysm Treatment
NCT04380350 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trenza Embolization Device for Intrasaccular Aneurysm Treatment
- Lead sponsor
- Stryker Neurovascular
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 17, 2020
- Completion date
- February 12, 2026
- Enrollment
- 150 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.